Northwest & Ethical Investments’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-27,513
Closed -$1.55M 490
2024
Q4
$1.55M Sell
27,513
-1,357
-5% -$84.4K 0.04% 274
2024
Q3
$1.97M Sell
28,870
-36,242
-56% -$2.05M 0.05% 252
2024
Q2
$2.75M Sell
65,112
-2,046
-3% -$113K 0.08% 226
2024
Q1
$4.64M Buy
67,158
+8,295
+14% +$525K 0.13% 179
2023
Q4
$4.35M Buy
58,863
+27,931
+90% +$1.83M 0.13% 195
2023
Q3
$2.11M Hold
30,932
0.07% 230
2023
Q2
$2.9M Sell
30,932
-14,214
-31% -$1.11M 0.09% 218
2023
Q1
$3.06M Sell
45,146
-1,227
-3% -$78.9K 0.1% 214
2022
Q4
$2.3M Buy
46,373
+6,082
+15% +$249K 0.08% 231
2022
Q3
$1.31M Hold
40,291
0.05% 270
2022
Q2
$1.59M Buy
40,291
+1,997
+5% +$107K 0.06% 259
2022
Q1
$2.68M Buy
38,294
+26,194
+216% +$1.91M 0.09% 225
2021
Q4
$942K Buy
+12,100
New +$1.07M 0.03% 310

Other funds holding EXAS

Northwest & Ethical Investments's EXAS Position: Q1 2025 in Review

Northwest & Ethical Investments sold out of Exact Sciences (EXAS) in Q1 2025, closing a stake of 27,513 shares — an estimated $1.55M sold.

Northwest & Ethical Investments first reported a position in EXAS in Q4 2021 and held it in 13 quarters. The position peaked at $4.64M in Q1 2024. 558 funds tracked by Wall St. Rank hold EXAS as of Q1 2025.

  • Northwest & Ethical Investments reported no remaining Exact Sciences position as of Q1 2025 after selling out during the quarter.
  • Northwest & Ethical Investments sold 27,513 Exact Sciences shares in Q1 2025, an estimated $1.55M.
  • Northwest & Ethical Investments first reported a position in Exact Sciences in Q4 2021 and held it in 13 quarters.
  • Northwest & Ethical Investments's Exact Sciences position peaked at $4.64M in Q1 2024.
  • 558 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2025.

Based on Northwest & Ethical Investments's 13F filing for Q1 2025, filed 13 May 2025.